Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

1. Genre, F.
2. López-Mejías, R.
3. Miranda-Filloy, J.A.
4. Ubilla, B.
5. Carnero-López, B.
6. Palmou-Fontana, N.
7. Gómez-Acebo, I.
8. Blanco, R.
9. Rueda-Gotor, J.
10. Pina, T.
11. González-Juanatey, C.
12. Llorca, J.
13. González-Gay, M.A.